Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance - PubMed (original) (raw)
Affiliations
- PMID: 18636144
Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance
Keisuke Nishihara et al. Int J Oncol. 2008 Aug.
Abstract
Minichromosome maintenance (MCM) proteins are essential components for DNA replication, and also prognostic markers for various human tumors. MCM-positive but Ki67-negative cells (e.g. primary oocytes) are thought to be licensed non-proliferating populations, and are significantly correlated with the clinicopathological profiles of some human tumors. In the present study, we evaluated the expression levels of MCM7, MCM2 and Ki67 in colorectal cancer to clarify their pathobiological significance. We carried out Western blot analyses of 5 human colorectal cancer cell lines and performed immunohistochemistry on 202 surgically removed colorectal cancers of Dukes' B and C stages. Double-labeling immunofluorescence was also carried out on the cancer specimens to identify MCM-positive but Ki67-negative tumor cells. MCM proteins were detected in all the 5 cell lines examined. MCM7 and MCM2 were coexpressed in almost the same populations of tumor cells, whereas MCM7-negative but Ki67-positive tumor cells were absent in the double-labeled specimens, except for mitotic cells. The mean positive tumor labeling indexes (LIs) for MCM7, MCM2 and Ki67 were 58.1, 57.1 and 40.6%, respectively. The mean LI for MCM7-positive but Ki67-negative tumor cells was 17.6%, and significantly correlated with the N status (P=0.01), distant metastasis (P=0.01) and UICC stage (P=0.02). The high LI of >58.1% for MCM7 were independent prognostic factors in multivariate Cox regression analysis (relative risk = 2.12; P=0.02). Our results indicate that MCM7 expression is an independent prognostic factor for human colorectal cancer, and MCM7-positive but Ki67-negative tumor cells are correlated with tumor metastases.
Similar articles
- Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
Fujioka S, Shomori K, Nishihara K, Yamaga K, Nosaka K, Araki K, Haruki T, Taniguchi Y, Nakamura H, Ito H. Fujioka S, et al. Lung Cancer. 2009 Aug;65(2):223-9. doi: 10.1016/j.lungcan.2008.11.007. Epub 2009 Jan 13. Lung Cancer. 2009. PMID: 19144445 - Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Li SS, Xue WC, Khoo US, Ngan HY, Chan KY, Tam IY, Chiu PM, Ip PP, Tam KF, Cheung AN. Li SS, et al. Histopathology. 2005 Mar;46(3):307-13. doi: 10.1111/j.1365-2559.2005.02069.x. Histopathology. 2005. PMID: 15720416 - Immunohistochemical expression of geminin in colorectal cancer: Implication of prognostic significance.
Nishihara K, Shomori K, Tamura T, Fujioka S, Ogawa T, Ito H. Nishihara K, et al. Oncol Rep. 2009 May;21(5):1189-95. doi: 10.3892/or_00000340. Oncol Rep. 2009. PMID: 19360293 - Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology.
Tachibana KE, Gonzalez MA, Coleman N. Tachibana KE, et al. J Pathol. 2005 Jan;205(2):123-9. doi: 10.1002/path.1708. J Pathol. 2005. PMID: 15643673 Review. - Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer.
Juríková M, Danihel Ľ, Polák Š, Varga I. Juríková M, et al. Acta Histochem. 2016 Jun;118(5):544-52. doi: 10.1016/j.acthis.2016.05.002. Epub 2016 May 28. Acta Histochem. 2016. PMID: 27246286 Review.
Cited by
- MCM7 expression is correlated with histological subtypes of lung adenocarcinoma and predictive of poor prognosis.
Wang H, Zhou C, Su B, Teng G, Zheng Y, Zhou X, Guo L, Xu F, Wang X. Wang H, et al. Int J Clin Exp Pathol. 2017 Dec 1;10(12):11747-11753. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966536 Free PMC article. - Minichromosome maintenance 2 is an independent predictor of survival in patients with lung adenocarcinoma.
Sakai H, Kimura H, Otsubo K, Miyazawa T, Marushima H, Kojima K, Chosokabe M, Furuya N, Koike J, Fujii K, Nishimura T, Nakamura H, Saji H. Sakai H, et al. Mol Clin Oncol. 2022 Jan;16(1):22. doi: 10.3892/mco.2021.2455. Epub 2021 Nov 30. Mol Clin Oncol. 2022. PMID: 34909200 Free PMC article. - Oncogenic activity of MCM7 transforming cluster.
Luo JH. Luo JH. World J Clin Oncol. 2011 Feb 10;2(2):120-4. doi: 10.5306/wjco.v2.i2.120. World J Clin Oncol. 2011. PMID: 21603321 Free PMC article. - Celastrol Modulates Multiple Signaling Pathways to Inhibit Proliferation of Pancreatic Cancer via DDIT3 and ATF3 Up-Regulation and RRM2 and MCM4 Down-Regulation.
Youns M, Askoura M, Abbas HA, Attia GH, Khayyat AN, Goda RM, Almalki AJ, Khafagy ES, Hegazy WAH. Youns M, et al. Onco Targets Ther. 2021 Jun 23;14:3849-3860. doi: 10.2147/OTT.S313933. eCollection 2021. Onco Targets Ther. 2021. PMID: 34194230 Free PMC article. - Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7.
Shi YK, Yu YP, Tseng GC, Luo JH. Shi YK, et al. Cancer Gene Ther. 2010 Oct;17(10):694-9. doi: 10.1038/cgt.2010.25. Epub 2010 Jun 11. Cancer Gene Ther. 2010. PMID: 20539323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous